Market revenue in 2023 | USD 2,306.1 million |
Market revenue in 2030 | USD 5,883.4 million |
Growth rate | 14.3% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics, Therapeutics |
Key market players worldwide | Roche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 80.87% in 2023. Horizon Databook has segmented the Italy precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
The advent of NGS has revolutionized the genomics industry in Italy over the years. This has led to the emergence of many innovative entities in the market. For instance, the Italian Society for Personalized Medicine (SIMeP) has emerged as an integral player in optimizing the National Health Service’s resources and improving patient care.
Furthermore, in January 2020, UPMC-managed ISMETT launched a new imaging laboratory in Palermo, Italy. With this launch, the organization aimed to initiate PM research projects with a focus on radiomics and big data. Such initiatives are expected to boost the adoption of personalized medicine in research settings.
Italy is leading this project with the involvement of two institutions: Fondazione Regionale per la Ricerca Biomedica and Fondazione Toscana Life Sciences. This project aims to support the development of personalized medicine by enhancing cross-regional collaborations.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into Italy precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account